Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunopharmacology and Immunotoxicology is Scopus-indexed (Q2, CiteScore 5.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0892-3973Verify ISSN ↗1532-2513Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 127 / 328 | 61st | Q2 |
| Toxicology | 56 / 131 | 57th | Q2 |
| Immunology and Allergy | 103 / 234 | 56th | Q2 |
| Immunology | 117 / 243 | 52nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1978–present, best quartile Q2, CiteScore 5.3.
Immunopharmacology and Immunotoxicology is Q2 in Pharmacology (rank 127 of 328), Q2 in Toxicology (rank 56 of 131) and Q2 in Immunology and Allergy (rank 103 of 234), by CiteScore 2025. It is ranked in 4 subject areas in all.
Immunopharmacology and Immunotoxicology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 61st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.723, quartile Q2, with an H-index of 67.
Immunopharmacology and Immunotoxicology is published by Taylor and Francis Ltd. Its print ISSN is 0892-3973 and its online ISSN is 1532-2513.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunopharmacology and Immunotoxicology has an h-index of 74 and a 2-year mean of 2.48 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #138 of 319 Scopus journals in Pharmacology.
Immunopharmacology and Immunotoxicology published 83 papers in 2025; its busiest recent year was 2022 with 140. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from China (35.6%), Egypt (14.5%) and Iran (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 34 retracted papers are recorded (12.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.